Jay Vee Overseas Private Limited
About Jay Vee Overseas Private Limited
Data last updated:
Jay Vee Overseas Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 June 2009.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51109DL2009PTC191409.
The company had an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10.6 Lakh.
Its last annual general meeting (AGM) was held on 31 July 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at C – 194 Vikas Puri, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2020, the company reported a revenue of ₹2.91 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹1.44 Lakh (net margin 49.4%) and EBITDA of ₹1.97 Lakh (EBITDA margin 67.7%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 14% over five years.
Company details
Contact details
Jay Vee Overseas Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 194 Vikas Puri, New Delhi, Delhi, India – 110018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jay Vee Overseas Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Jay Vee Overseas Private Limited
FY 2020 filings availableJay Vee Overseas Private Limited reported revenue of ₹2.91 Lakh (down 30% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 30% fall in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 67.7% | ||||
| Net Profit Margin | 49.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jay Vee Overseas Private Limited, buy the company report.
Board of directors of Jay Vee Overseas Private Limited
Jay Vee Overseas has 2 former directors on record and no current directors listed.
Peer comparison
Jay Vee Overseas Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Systochem Formulations Private Limited | ₹2.95 Lakh (FY 2025) | 10.0% | Delhi, India | |||
| Shri Balaji Dhanush Healthtech Private Limited | ₹2.95 Lakh (FY 2025) | -89.0% | Raipur, Chhattisgarh, India | |||
| Asclepius Remedies Private Limited | ₹2.93 Lakh (FY 2024) | -30.0% | Indore, Madhya Pradesh, India | |||
| Pinon Healthcare Private Limited | ₹2.93 Lakh (FY 2021) | -59.0% | Sabarmati, Gujarat, India | |||
| Piquant Scientific Private Limited | ₹2.93 Lakh (FY 2024) | -83.0% | Delhi, India | |||
| Jay Vee Overseas Private Limitedthis company | ₹2.91 Lakh (FY 2020) | ₹1.44 Lakh | 49.4% | -30.0% | New Delhi, Delhi, India | |
| Pushpak Pharma Chem Private Ltd | ₹2.91 Lakh (FY 2024) | -50.0% | Delhi, India | |||
| Rishmaan Lifesciences Private Limited | ₹2.89 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Pajuvir Pharma Private Limited | ₹2.88 Lakh (FY 2025) | -16.0% | Pune, Maharashtra, India | |||
| Zenova Life Private Limited | ₹2.87 Lakh (FY 2025) | Bhopal, Madhya Pradesh, India | ||||
| Sanrajtosh Pharmaceutical Private Limited | ₹2.86 Lakh (FY 2025) | -51.0% | Panchkula, Haryana, India |
To see the full peer comparison of Jay Vee Overseas Private Limited, buy the company report.
Auditor
Jay Vee Overseas Private Limited is audited by S P M S & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P M S & ASSOCIATES | FY 2019 | 015808N |
Shareholding
The shareholding of Jay Vee Overseas Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Jay Vee Overseas Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jay Vee Overseas Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jay Vee Overseas Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Jay Vee Overseas Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jay Vee Overseas Private Limited has 2 board changes on record since 2020: 0 appointments and 2 cessations. The latest: Ravinder Kumar Gupta ceased to be Director on 27 Aug 2020.
Frequently asked questions
Jay Vee Overseas has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Jay Vee Overseas was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 June 2009 and is registered under CIN U51109DL2009PTC191409. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Jay Vee Overseas is U51109DL2009PTC191409. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jay Vee Overseas was incorporated on 19 June 2009. It is registered with the Registrar of Companies, Delhi.
The registered office of Jay Vee Overseas is at C – 194 Vikas Puri, New Delhi, Delhi, India – 110018.
The latest financial statements of Jay Vee Overseas on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 July 2020. Year-wise statements from 2015 are in the company report.
Jay Vee Overseas operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Jay Vee Overseas by revenue are Systochem Formulations Private Limited, Shri Balaji Dhanush Healthtech Private Limited, Asclepius Remedies Private Limited, Pinon Healthcare Private Limited, Piquant Scientific Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Ravinder Kumar Gupta ceased to be Director on 27 Aug 2020. Renu Gupta ceased to be Director on 27 Aug 2020.
The compliance status of Jay Vee Overseas is compliant as of 01 July 2026.
Jay Vee Overseas can be reached at its registered office: C – 194 Vikas Puri, New Delhi, Delhi, India – 110018.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
